145 related articles for article (PubMed ID: 20840107)
1. Gene delivery in the equine cornea: a novel therapeutic strategy.
Buss DG; Giuliano E; Sharma A; Mohan RR
Vet Ophthalmol; 2010 Sep; 13(5):301-6. PubMed ID: 20840107
[TBL] [Abstract][Full Text] [Related]
2. Canine corneal fibroblast and myofibroblast transduction with AAV5.
Bosiack AP; Giuliano EA; Gupta R; Mohan RR
Vet Ophthalmol; 2012 Sep; 15(5):291-8. PubMed ID: 22151250
[TBL] [Abstract][Full Text] [Related]
3. Efficacious and safe tissue-selective controlled gene therapy approaches for the cornea.
Mohan RR; Sinha S; Tandon A; Gupta R; Tovey JC; Sharma A
PLoS One; 2011 Apr; 6(4):e18771. PubMed ID: 21533273
[TBL] [Abstract][Full Text] [Related]
4. Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy.
Mohan RR; Tandon A; Sharma A; Cowden JW; Tovey JC
Invest Ophthalmol Vis Sci; 2011 Jul; 52(7):4833-41. PubMed ID: 21551414
[TBL] [Abstract][Full Text] [Related]
5. Decorin-PEI nanoconstruct attenuates equine corneal fibroblast differentiation.
Donnelly KS; Giuliano EA; Sharma A; Tandon A; Rodier JT; Mohan RR
Vet Ophthalmol; 2014 May; 17(3):162-9. PubMed ID: 23718145
[TBL] [Abstract][Full Text] [Related]
6. Tissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo.
Mohan RR; Gupta S; Kumar R; Sinha NR; Landreneau J; Sinha PR; Tandon A; Chaurasia SS; Hesemann NP
Ocul Surf; 2024 Apr; 32():13-25. PubMed ID: 38191093
[TBL] [Abstract][Full Text] [Related]
7. Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy.
Liu J; Saghizadeh M; Tuli SS; Kramerov AA; Lewin AS; Bloom DC; Hauswirth WW; Castro MG; Schultz GS; Ljubimov AV
Mol Vis; 2008; 14():2087-96. PubMed ID: 19023450
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of Pirfenidone for treating equine corneal scarring.
Fink MK; Giuliano EA; Tandon A; Mohan RR
Vet Ophthalmol; 2015 May; 18(3):242-50. PubMed ID: 25041235
[TBL] [Abstract][Full Text] [Related]
9. Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo.
Gupta S; Fink MK; Kempuraj D; Sinha NR; Martin LM; Keele LM; Sinha PR; Giuliano EA; Hesemann NP; Raikwar SP; Chaurasia SS; Mohan RR
Mol Ther; 2022 Oct; 30(10):3257-3269. PubMed ID: 35780298
[TBL] [Abstract][Full Text] [Related]
10. Altering equine corneal fibroblast differentiation through Smad gene transfer.
Marlo TL; Giuliano EA; Tripathi R; Sharma A; Mohan RR
Vet Ophthalmol; 2018 Mar; 21(2):132-139. PubMed ID: 28685927
[TBL] [Abstract][Full Text] [Related]
11. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F
J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631
[TBL] [Abstract][Full Text] [Related]
12. AAV serotype influences gene transfer in corneal stroma in vivo.
Sharma A; Tovey JC; Ghosh A; Mohan RR
Exp Eye Res; 2010 Sep; 91(3):440-8. PubMed ID: 20599959
[TBL] [Abstract][Full Text] [Related]
13. The human rhodopsin kinase promoter in an AAV5 vector confers rod- and cone-specific expression in the primate retina.
Boye SE; Alexander JJ; Boye SL; Witherspoon CD; Sandefer KJ; Conlon TJ; Erger K; Sun J; Ryals R; Chiodo VA; Clark ME; Girkin CA; Hauswirth WW; Gamlin PD
Hum Gene Ther; 2012 Oct; 23(10):1101-15. PubMed ID: 22845794
[TBL] [Abstract][Full Text] [Related]
14. Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo.
Mohan RR; Tovey JC; Sharma A; Schultz GS; Cowden JW; Tandon A
PLoS One; 2011; 6(10):e26432. PubMed ID: 22039486
[TBL] [Abstract][Full Text] [Related]
15. [A novel packaging system of recombinant AAV5/5 vector].
Dong X; Tian W; Yuan Z; Tan S; Wu X
Sheng Wu Gong Cheng Xue Bao; 2010 May; 26(5):679-86. PubMed ID: 20684314
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus vector mediated gene transfer to pancreatic beta cells.
Prasad KM; Yang Z; Bleich D; Nadler JL
Gene Ther; 2000 Sep; 7(18):1553-61. PubMed ID: 11021593
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.
Li W; Kong F; Li X; Dai X; Liu X; Zheng Q; Wu R; Zhou X; Lü F; Chang B; Li Q; Hauswirth WW; Qu J; Pang JJ
Mol Vis; 2009; 15():267-75. PubMed ID: 19190735
[TBL] [Abstract][Full Text] [Related]
18. Six-Month In Vivo Safety Profiling of Topical Ocular AAV5-Decorin Gene Transfer.
Mohan RR; Balne PK; Muayad MS; Tripathi R; Sinha NR; Gupta S; An JA; Sinha PR; Hesemann NP
Transl Vis Sci Technol; 2021 Aug; 10(10):5. PubMed ID: 34383877
[TBL] [Abstract][Full Text] [Related]
19. Human blue-opsin promoter preferentially targets reporter gene expression to rat s-cone photoreceptors.
Glushakova LG; Timmers AM; Pang J; Teusner JT; Hauswirth WW
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3505-13. PubMed ID: 16877422
[TBL] [Abstract][Full Text] [Related]
20. Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo.
Gupta S; Rodier JT; Sharma A; Giuliano EA; Sinha PR; Hesemann NP; Ghosh A; Mohan RR
PLoS One; 2017; 12(3):e0172928. PubMed ID: 28339457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
